Gómez, E., Mir, A., De los Santos, M. J., Pellicer, A., & Simón, C. (1992). Glucocorticoid treatment decreases sera embryotoxicity in endometriosis patients. Fertility and Sterility, 58(2), 284-289. https://doi.org/10.1016/s0015-0282(16)55198-x
Gómez E, Mir A, De los Santos MJ, Pellicer A, Simón C. Glucocorticoid treatment decreases sera embryotoxicity in endometriosis patients. Fertil Steril. 1992;58(2):284-289. doi:10.1016/s0015-0282(16)55198-x
Gómez, E., et al. "Glucocorticoid treatment decreases sera embryotoxicity in endometriosis patients." Fertility and Sterility, vol. 58, no. 2, 1992, pp. 284-289.
For EndNote, Zotero or Mendeley:
Open access
Free to read
No reuse license
Free to read at the publisher (reported by Unpaywall and OpenAlex, not verified by RRM Academy)
Glucocorticoids lowered mouse-embryo toxicity of endometriosis serum
A 1992 prospective study of eight women with mild to moderate endometriosis found their serum appeared less toxic to mouse embryos in a laboratory dish after a 3-day glucocorticoid course. At 50% serum concentration, no embryos reached blastocyst in untreated serum. By day 12, about 3 out of 10 did, against about 6 out of 10 in control serum.
Key Findings
The study compared serum from eight women with endometriosis and eight women with tubal infertility; 232 two-cell mouse embryos were cultured across eight experiments.
In 50% serum, 0% of embryos grew to the blastocyst stage by 72 hours with basal endometriosis serum. Control serum gave 61% (P < 0.001).
Serum drawn 12 days after treatment allowed 32.4% to reach the blastocyst stage (T4 versus basal, P < 0.001), still below nontoxic levels (>50%).
Interleukin 1 alpha was undetectable in every sample. Antismooth muscle antibody appeared in the endometriosis sera and dropped significantly 3 days after treatment.
Interpretation
The study is a small prospective longitudinal design that measured embryo growth in a laboratory dish, using mouse embryos to test human serum. The outcomes were embryo development to the morula stage at 48 hours and to the blastocyst stage at 72 hours, and the women were followed for serum changes only. Serum at 7.5% concentration showed no significant differences. The authors state that the relevance of the antismooth muscle antibody finding remains to be established in further studies.
RRM Context
At 50% concentration, serum from women with endometriosis appeared toxic to mouse embryos in a laboratory dish, and that effect shifted with treatment. The result points to the body's own immune environment as a possible source of endometriosis-related infertility. Restorative reproductive medicine looks for such underlying causes. The authors work at an IVF clinic and frame the finding around embryo transfer. IVF proceeds without resolving the cause of that toxicity.
Our editorial summary of this paper, not the article's abstract.
Abstract
Objective
To investigate the effect of short-term glucocorticoid administration on embryotoxicity of sera from infertile patients with mild to moderate endometriosis.
Design
Prospective longitudinal study.
SETTING,
Patients
Eight infertile patients with mild to moderate endometriosis and a control group of eight infertile patients with tubal infertility were selected on the basis of laparoscopic examination.
Interventions
Basal (B) serum collection and day 1 (T1), day 3 (T2), day 6 (T3), and day 12 (T4) serum drawn after a 3-day glucocorticoid treatment in endometriosis patients.
Main Outcome Measures
Embryotoxicity of endometriosis sera, before and after glucocorticoid treatment, was investigated using a bioassay performed on two-cell mouse embryos. Interleukin 1 alpha (IL-1 alpha) and antismooth muscle, antimitochondrial, and antinuclear autoantibodies were also tested in these sera.
Results
At 50% concentration, endometriosis serum is embryotoxic in comparison with control; 0% versus 61% of the embryos reached the blastocyst stage at 72 hours, respectively (basal versus control, P less than 0.001). However, this embryotoxicity significantly decreases 12 days after glucocorticoid treatment in comparison with untreated sera; 32.4% versus 0% of the embryos reached blastocyst stage at 72 hours, respectively (T4 versus basal, P less than 0.001), although they did not reach nontoxic levels (greater than 50%). Interleukin 1 alpha was undetectable in all samples analyzed. In endometriosis sera, antismooth muscle antibody was detected.
Conclusions
At 50% concentration, serum from infertile patients with minimal to moderate endometriosis appears to be embryotoxic to the in vitro development of two-cell mouse embryos. However, this embryotoxicity significantly decreases 12 days after a 3-day treatment with glucocorticoids.
Endometriosis is a chronic inflammatory disease that drives pain, organ dysfunction, and infertility. How RRM-trained clinicians diagnose and treat it through excision surgery, cycle charting, and longitudinal care.